Hossein Akhondi Asl, MD
Internal Medicine · Henderson, NVNPI 1609862051
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Gilead at 52.2% of the total. 2024 is the largest year on record at $6,892, 2.6 times the $2,662 reported in 2019. Among internal medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $93.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$7K
- Novo Nordisk$1K
- AstraZeneca$728
- Johnson & Johnson$428
- AbbVie$414
- E.r. Squibb & Sons, L.L.C.$400
- plus $3K from 21 others
What the payments were for
- Consulting fees$4,56037%
- Travel & lodging$1,0899%
- Food & beverage$6,82955%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 20 | $6,517 |
| Novo Nordisk | 25 | $1,088 |
| AstraZeneca(2 entities) | 10 | $728 |
| Johnson & Johnson(2 entities) | 10 | $428 |
| AbbVie(2 entities) | 7 | $414 |
| E.r. Squibb & Sons, L.L.C. | 13 | $400 |
| Shionogi Inc | 4 | $292 |
| Janssen Products, LP | 2 | $249 |
| Paratek Pharmaceuticals, Inc. | 3 | $249 |
| Merck | 5 | $238 |
| Melinta Therapeutics, LLC | 2 | $220 |
| Pfizer | 10 | $199 |
| Mylan Specialty L.p. | 4 | $178 |
| Sanofi | 1 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| Genentech USA, Inc. | 1 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| KCI USA, Inc. | 1 | $122 |
| Sunovion Pharmaceuticals Inc. | 1 | $120 |
| Abbott | 4 | $114 |
| Jazz Pharmaceuticals Inc. | 1 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $100 |
| Portola Pharmaceuticals, LLC | 1 | $94 |
| Edwards Lifesciences | 1 | $55 |
| Novartis | 2 | $34 |
| Boehringer Ingelheim | 1 | $16 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,477 in reported general payments places this provider in the 95th percentile of 1,071 internal medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Henderson
- Ryan HamptonHenderson$233K
- Justin TerryHenderson$19K
- Sonu BhatiaHenderson$18K
- Russell NeibaurHenderson$15K
- John GarrisonHenderson$14K
- Ran JiaHenderson$11K
- Mavis MatsumotoHenderson$11K
- Brandon JensenHenderson$10K
- Michael BlochReno$475K
- Kevin DunsmoorLas Vegas$241K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.